... AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a state-ment from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood ... other diseases such as systemic lupus, rheumatoid arthritis, other connective tissue diseases, liver disease, malnu-trition from other causes, and does not just represent cardiovascular disease. ... D. Cardiovasculardisease and mortality in a community based cohort with mild renal insufficiency. Kidney Int. 1999; 56: 2214-19. 6. Shilpak MG, Fried LF, Crump C et al. Cardiovascular disease...
... Function, Valvular Heart Disease, Cardiovascular Pharmacology and Drug Therapy, Acute Cardiac Care, Cardiovascular Surgery.Councils: Cardiology Practice, Cardiovascular Primary Care, Cardiovascular Imaging. ... 3195ESC GUIDELINESESC Guidelines on the management of cardiovascular diseases during pregnancyThe Task Force on the Management of Cardiovascular Diseasesduring Pregnancy of the European Society ... world, congenital heart disease is the most frequent cardiovascular disease present during pregnancy (75– 82%), withshunt lesions predominating (20–65%).11,12Congenital heart disease represents...
... Progress in Cardiovascular Diseases 27 (5): 335–71.662 | Disease Control Priorities in Developing Countries | Thomas A. Gaziano, K. Srinath Reddy, Fred Paccaud, and others Cardiovascular Disease ... CaribbeanSub-SaharanAfrica Cardiovascular diseasesMalignant neoplasmsInjuriesRespiratory infectionsChronic lung diseasesHIV/AIDSFigure 33.2 Percentage Change in Ischemic Heart Disease DeathRates ... ofPatients with Acute Myocardial Infarction).” Circulation 110 (5):588–636. Cardiovascular Disease | 659645 Cardiovascular disease (CVD) is the number one cause ofdeath worldwide (Mathers and others...
... al. MicroRNAs and cardiovascular diseasesFEBS Journal 278 (2011) 1619–1633 ª 2011 The Authors Journal compilation ª 2011 FEBS 1631MINIREVIEWMicroRNAs and cardiovascular diseasesKoh Ono1,2, ... and, for thisMicroRNAs and cardiovascular diseases K. Ono et al.1622 FEBS Journal 278 (2011) 1619–1633 ª 2011 The Authors Journal compilation ª 2011 FEBS Cardiovascular disease is the leading cause ... revealed distinct rolesfor specific miRNAs in cardiovascular development and physiological func-tion. The implications of miRNAs in cardiovasculardisease have recentlybeen recognized, representing...
... in the cardiovasculardisease mortality and YLL, and the transition towards cancer. In more recent years, the highest burdens of disease came from cancers in men and from cardiovascular diseases ... life lost from cancer were also higher than from cardiovascular diseases. Among women, despite the decrease in death rates, cardiovascular diseases remained the leading cause of death in 2010 ... rate from all cardiovascular diseases was more than two-fold higher than cancer mortality in 1980. However, three decades later mortality from cancer surpassed cardiovascular diseases. After...
... interval)Exposure All causes(n = 5534) Cardiovascular disease (n = 1285)Ischemic heart disease (n = 548)Cerebrovascular d isease(n = 292)Other cardiovascular disease (n = 376)NO2from 1971 onwardsb1.13 ... mortality from cardiovasculardisease and 1.25 (95% CI, 1.11–1.42) for mortality from all causes.Conclusions: Traffic air pollution is associated with mortality from cardiovascular diseases and ... been associated with morbidity and mortalityfrom cardiovasculardisease [10]. Furthermore, air pollu-tion could affect the risk for cardiovascular disease through mechanisms involving systemic...
... NICE public health guidance 25: Prevention of cardiovasculardisease Page 2 of 124 NICE public health guidance 25 Prevention of cardiovasculardisease at population level Ordering information ... public health guidance 25: Prevention of cardiovasculardisease Page 6 of 124 1 Recommendations This is NICE’s formal guidance on preventing cardiovasculardisease (CVD) at population level. When ... billion and £0.9 billion respectively. Reducing population cardiovascular risk by NICE public health guidance 25: Prevention of cardiovasculardisease Page 47 of 124 overweight (Harder et al. 2005)...
... The atlas of heart disease and stroke: The global burden of coronary heart disease. [pdf] Geneva: World Health Organization. Available at: <http://www.who.int /cardiovascular_ diseases/en/cvd_atlas_13_coronaryHD.pdf> ... Mumbai and cardiovascular disease Over the past decades, cardiovascular illness has exploded in India, with the country seeing a rapid rise in the prevalence of coronary heart disease [Ajay ... Tehran and cardiovascular disease In 2002, nearly 82,000 people died from heart disease across Iran, and just under 32,000 people died from stroke [WHO, 2004 (b)]. The burden of disease caused...
... neovascularization targets angiogenic growthfactors.198 GENE THERAPY IN CARDIOVASCULAR DISEASE CHAPTER 8Gene Therapy in Cardiovascular Disease VICTOR J. DZAU, M.D., AFSHIN EHSAN, M.D., and MICHAEL J. ... the treatment of a common cardiovascular disorder.With the development of viral-mediated gene delivery methods, some investiga-192 GENE THERAPY IN CARDIOVASCULAR DISEASE in the affected area. ... progression of acquired diseases has created a prospect for revolutionizing the clinician’s approach to common disorders. Noting the demo-graphics of cardiovascular diseases in the population...